» Articles » PMID: 25927331

Raman Spectroscopic Sensing of Carbonate Intercalation in Breast Microcalcifications at Stereotactic Biopsy

Overview
Journal Sci Rep
Specialty Science
Date 2015 May 1
PMID 25927331
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Microcalcifications are an early mammographic sign of breast cancer and frequent target for stereotactic biopsy. Despite their indisputable value, microcalcifications, particularly of the type II variety that are comprised of calcium hydroxyapatite deposits, remain one of the least understood disease markers. Here we employed Raman spectroscopy to elucidate the relationship between pathogenicity of breast lesions in fresh biopsy cores and composition of type II microcalcifications. Using a chemometric model of chemical-morphological constituents, acquired Raman spectra were translated to characterize chemical makeup of the lesions. We find that increase in carbonate intercalation in the hydroxyapatite lattice can be reliably employed to differentiate benign from malignant lesions, with algorithms based only on carbonate and cytoplasmic protein content exhibiting excellent negative predictive value (93-98%). Our findings highlight the importance of calcium carbonate, an underrated constituent of microcalcifications, as a spectroscopic marker in breast pathology evaluation and pave the way for improved biopsy guidance.

Citing Articles

Use of artificial intelligence in breast surgery: a narrative review.

Seth I, Lim B, Joseph K, Gracias D, Xie Y, Ross R Gland Surg. 2024; 13(3):395-411.

PMID: 38601286 PMC: 11002485. DOI: 10.21037/gs-23-414.


Exploration of utility of combined optical photothermal infrared and Raman imaging for investigating the chemical composition of microcalcifications in breast cancer.

Bouzy P, Lyburn I, Pinder S, Scott R, Mansfield J, Moger J Anal Methods. 2023; 15(13):1620-1630.

PMID: 36880909 PMC: 10065137. DOI: 10.1039/d2ay01197b.


Diagnosis accuracy of Raman spectroscopy in the diagnosis of breast cancer: a meta-analysis.

Wang M, Liu X, Wang Q, Zhang H Anal Bioanal Chem. 2022; 414(27):7911-7922.

PMID: 36138121 DOI: 10.1007/s00216-022-04326-7.


Raman spectroscopy reveals phenotype switches in breast cancer metastasis.

Paidi S, Rodriguez Troncoso J, Harper M, Liu Z, Nguyen K, Ravindranathan S Theranostics. 2022; 12(12):5351-5363.

PMID: 35910801 PMC: 9330538. DOI: 10.7150/thno.74002.


Unravelling the Encapsulation of DNA and Other Biomolecules in HAp Microcalcifications of Human Breast Cancer Tissues by Raman Imaging.

Marro M, Rodriguez-Rivero A, Araujo-Andrade C, Fernandez-Figueras M, Perez-Roca L, Castella E Cancers (Basel). 2021; 13(11).

PMID: 34071374 PMC: 8198780. DOI: 10.3390/cancers13112658.


References
1.
Holton S, Bergamaschi A, Katzenellenbogen B, Bhargava R . Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer. PLoS One. 2014; 9(5):e96878. PMC: 4016150. DOI: 10.1371/journal.pone.0096878. View

2.
Tabar L, Chen H, Duffy S, Yen M, Chiang C, Dean P . A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000; 355(9202):429-33. DOI: 10.1016/s0140-6736(00)82008-5. View

3.
Motz J, Hunter M, Galindo L, Gardecki J, Kramer J, Dasari R . Optical fiber probe for biomedical Raman spectroscopy. Appl Opt. 2004; 43(3):542-54. DOI: 10.1364/ao.43.000542. View

4.
Wiens R, Rak M, Cox N, Abraham S, Juurlink B, Kulyk W . Synchrotron FTIR microspectroscopic analysis of the effects of anti-inflammatory therapeutics on wound healing in laminectomized rats. Anal Bioanal Chem. 2007; 387(5):1679-89. DOI: 10.1007/s00216-006-1095-9. View

5.
Pezzotti G, Sakakura S . Study of the toughening mechanisms in bone and biomimetic hydroxyapatite materials using Raman microprobe spectroscopy. J Biomed Mater Res A. 2003; 65(2):229-36. DOI: 10.1002/jbm.a.10447. View